# Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome

> **NCT01088503** · — · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 12227 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** ADP receptor inhibitors

## Key facts

- **NCT ID:** NCT01088503
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 12227 (ACTUAL)
- **Last updated:** 2016-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088503, "Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01088503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*